Next Article in Journal
Machine Learning-Assisted Catalysts for Advanced Oxidation Processes: Progress, Challenges, and Prospects
Next Article in Special Issue
Frequency-Resolved Modulation Excitation Spectroscopy Methodology for Identifying Surface Reaction Species in Ethanol Oxidation on Gold Catalysts
Previous Article in Journal
A Review on Green Hydrogen Production by Aqueous Phase Reforming of Lignocellulose and Derivatives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Antimicrobial Activity of Chalcone-Derived 1,4-Dihydropyridine Derivatives Using Magnetic Fe2O3@SiO2 as Highly Efficient Nanocatalyst

1
Materials and Natural Product Laboratory, Department of Chemistry, Chandigarh University, Gharuan, Mohali 140413, Punjab, India
2
Department of Chemistry and Biochemistry, University of Nevada Las Vegas, 4505 S. Maryland Parkway, Box 454003, Las Vegas, NV 89154, USA
3
Department of Food Science and Nutrition, College of Food and Agriculture Sciences, King Saud University, Riyadh 11451, Saudi Arabia
4
Department of Applied Science, Chandigarh Engineering College, Chandigarh Group of Colleges Jhanjeri, Kharar, Mohali 140307, Punjab, India
*
Author to whom correspondence should be addressed.
Catalysts 2025, 15(3), 281; https://doi.org/10.3390/catal15030281
Submission received: 12 February 2025 / Revised: 10 March 2025 / Accepted: 13 March 2025 / Published: 17 March 2025
(This article belongs to the Special Issue Spectroscopy in Modern Materials Science and Catalysis)

Abstract

:
The growing threat of bacterial resistance, coupled with the increasing costs associated with drug development, poses significant challenges in the discovery of new antibiotics. The present study reports the synthesis and antimicrobial evaluation of 1,4-dihydropyridine (1,4-DHP) derivatives derived from chalcones, using silica-mediated magnetic iron oxide, Fe2O3@SiO2 nanoparticles as a nanocatalyst. The nanoparticles were characterized using FT-IR, SEM-EDS, XRD, Zeta-Potential, and VSM techniques to confirm their structure and properties. Among them, the series 8ae (particularly compound 8c) demonstrated strong antimicrobial activity, with effectiveness comparable to standard drugs Fluconazole and Amoxicillin; this was attributed to the presence of polar groups. Other derivatives exhibited moderate activity, with MICs ranging from 25 to 50 μg/mL, while no significant activity was observed against Gram-negative bacteria. These compounds hold potential as promising antimicrobial agents and warrant further investigation for the development of effective therapies.

1. Introduction

The rapid advancements in drug development continue to captivate academia, the global economy, and the pharmaceutical sector [1]. In this dynamic landscape, contemporary multicomponent reactions (MCRs) have emerged as transformative tools, overcoming the limitations of conventional step-by-step synthesis [2]. MCRs enable highly selective, atom–economical reactions with unparalleled efficiency, offering significant advantages in the synthesis of pharmaceutical agents, antibiotics, and unique biological receptors [3,4]. To address the growing demand for innovative drug discovery, the strategic utilization of existing molecular scaffolds with inherent biological potential has become a priority [5]. These scaffolds serve as foundational frameworks for constructing novel molecular libraries, while adopting highly efficient synthetic strategies further accelerates progress in this critical area [6].
Among these scaffolds, chalcones have gained prominence due to their natural abundance, diverse biological activities, and versatility as precursors for complex heterocyclic transformations [7,8]. Naturally occurring chalcones, such as xanthohumol, isoliquiritigenin, and isobavachalcone, exhibit an extensive range of pharmacological properties, including anti-cancer, anti-inflammatory, antioxidant, anti-diabetic, anti-pigmentation, antimicrobial, and antibiotic effects [9,10]. Moreover, commercially available chalcone derivatives, such as metochalcone [11], sofalcone [12], and hesperidin methylchalcone [13], are widely used for their choleretic, anti-ulcer, and vascular protective properties. The chalcone framework has also been extensively explored for synthesizing derivatives such as pyrazolines, imidazoles, oxazolines, pyrimidines, and pyridines [14]. These synthetic endeavors have significantly enhanced the biological potential of chalcone derivatives, unlocking new therapeutic possibilities [15].
In contrast, 1,4-dihydropyridines (1,4-DHPs) have established themselves as pivotal bioactive compounds, renowned for their exceptional pharmaceutical profiles [16]. As the core structure in widely used drugs like nifedipine [17], amlodipine [18], nicardipine [15], and nimodipine [19], 1,4-DHPs are indispensable in treating hypertension and related cardiovascular conditions as calcium channel blockers [20]. Beyond this primary role, they exhibit a comprehensive field of biological activities, including anti-tumor, anti-inflammatory, anti-tubercular, anti-diabetic, antioxidant, anti-mutagenic, antibiotic, and antimicrobial effects [21]. Traditional synthesis approaches have long been employed for 1,4-DHPs synthesis, but they often suffer from limitations like prolonged reaction times, low yields, and limited selectivity [16,22]. Recent advancements have introduced innovative strategies to enhance efficiency, including the use of nanocatalysts (e.g., ferric oxide, nickel, tin dioxide, magnesium oxide) and advanced techniques such as microwave and ultrasonic-assisted methods [23,24]. Moreover, the synthesis of 1,4-dihydropyridines utilizing MnFe2O3 and nano-Fe2O3 nanoparticles as a catalyst provides high yields, selectivity, and purity, along with short reaction times and reusability, all under environmentally friendly conditions [25,26].
Interestingly, the convergence of biologically active chalcone scaffolds with the pursuit of 1,4-DHPs bearing hybrid properties holds immense promise [27]. This approach not only enriches the synthetic landscape but also unveils a captivating avenue for investigating their collective impact on biological attributes [28]. Building on our previous work with 1,4-DHPs and chalcone derivatives, we report the synthesis of 1,4-DHPs derived from chalcone frameworks. This approach marks a significant step toward designing innovative molecules with hybrid properties and expanded biological applications.

2. Result and Discussion

2.1. Synthesis of Fe2O3@SiO2 Nanocatalyst

The Fe2O3 nanoparticles were created using the co-precipitation method based on our earlier research. We dissolved 12 g of FeCl3 and 6 g of FeSO4·7H2O in 100 mL of deionized water, then purged the solution with N2 gas and stirred it for 1 h. To adjust the pH to around 10, we added ammonia solution (25%) dropwise. The mixture was then heated to 70 °C while continuously stirring and purging with N2 gas for 5 h, resulting in a black precipitate. Afterward, we filtered the precipitate, washed it with acetone and deionized water, and dried it in a vacuum oven at 60 °C. For the SiO2 coating, we dissolved 3 g of TEOS in 50 mL of ethanol and added 1 mL of ammonium hydroxide for hydrolysis. We then dispersed 2 g of Fe2O3 nanoparticles in 100 mL of ethanol, mixed it with the SiO2 sol, stirred for 4 h, filtered, washed with ethanol, and dried at 60 °C to obtain the Fe2O3@SiO2 nanoparticles.

2.2. Characterization of Fe2O3@SiO2 Nanoparticles

2.2.1. FT-IR Characterization

The FT-IR spectra of Fe2O3 and Fe2O3@SiO2 nanoparticles, illustrated in Figure 1, revealed several characteristic differences in their functional groups, indicating successful silica coating on the Fe2O3 core. In the spectrum of Fe2O3, the characteristic peak at 796 and 552 cm−1 attributes to Fe-O stretching vibrations, confirming the existence of iron oxide as the core material. However, the spectrum lacks any peaks associated with silica, as expected for pure Fe2O3. The adsorption band at 3464 cm−1 corresponds to the O-H groups (stretching vibrations) present in the nanoparticles.
In the contrast, the spectrum of Fe2O3@SiO2 nanoparticles displays additional peaks that signify the existence of silica. The absorption band observed at 544 cm−1 is associated with the bending vibration mode of Fe2O3, providing further evidence of the iron oxide phase within the nanocomposite.
A prominent peak at 3396 cm−1, along with another peak at 1629 cm−1, corresponds to the bending vibrations of O-H groups, respectively, indicating the presence of adsorbed water molecules on the surface of the nanoparticles. These peaks confirm the hydrophilic nature of the material, which is a common feature of such nanostructures [29]. Moreover, the distinct band detected at 1061 cm−1 corresponds to the antisymmetric stretching vibrations of Si-O-Si bonds, confirming the presence of silicon dioxide (SiO2). This band is indicative of the SiO2 shell that encapsulates the Fe2O3 core, forming the core–shell structure of the nanoparticles.
The combination of these characteristic peaks verifies the successful synthesis of Fe2O3@SiO2 nanoparticles. The Fe2O3 core contributes to the redox properties essential for synthesis, while the SiO2 shell ensures stability, prevents aggregation, and provides a large surface area for interaction with reactants.

2.2.2. DLS and Zeta-Potential Characterization

The Zeta-potential analysis of Fe2O3 and Fe2O3@SiO2 nanoparticles reveals significant differences in their surface charge stability, as demonstrated in Figure 2a. The Fe2O3 nanoparticles exhibit a Zeta-potential value of −20.5 mV, indicating a moderately stable colloidal dispersion. In contrast, the Fe2O3@SiO2 nanoparticles show an enhanced Zeta-potential of −32.8 mV, which is attributed to the silica coating. The silica shell introduces additional surface functional groups, which improve electrostatic repulsion between particles, thus enhancing their colloidal stability.
The Dynamic Light Scattering (DLS) analysis provides insight into the particle size and distribution, as demonstrated in Figure 2b. The Fe2O3 nanoparticles have a hydrodynamic diameter of 92.89 nm, while the silica coating increases the particle size to about 187.67 nm for Fe2O3@SiO2. The increase in size is attributed to the formation of a uniform silica shell around the Fe2O3 core [30].

2.2.3. XRD Characterization

The crystalline structure of the Fe2O3@SiO2 nanoparticles was examined via XRD analysis, utilizing Cu Kα radiation (λ = 1.54060 Å) with a scanning rate of 0.2 s over a range of 2θ = 20–70° and a step size of 10°. In the analysis of diffraction patterns, as shown in Figure 3, the peak observed at 30.25° was associated with the (110) crystallographic orientations of iron, indicating that the iron atoms in the sample were not fully oxidized. Further, other discernible peaks corresponding to the (012), (104), (110), (113), (024), and (116) crystallographic planes of a cubic structure of Fe2O3 were identified using standard data [31]. The formed XRD patterns correspond to the characteristic α-Fe2O3 pattern (JCPDS No. 33-0664). Additionally, a peak attributed to SiO2 with (011) crystallographic orientations was evident in the figure. With the crystallite size estimated at approximately 30 nm, it can be concluded that the Fe2O3@SiO2 nanoparticles exhibit a nano-crystalline structure [32].
The XRD characterization of Fe2O3@SiO2 nanoparticles reveals valuable information about their crystalline structure and phase composition. The diffraction pattern shows sharp peaks corresponding to the (012), (104), (110), (113), (024), and (116) crystalline phases of Fe2O3, specifically the hematite phase, which confirms the successful synthesis of iron oxide nanoparticles with a well-ordered crystalline structure. In addition, the broad hump observed in the 20–30° 2θ region indicates the presence of amorphous silica (SiO2), which is characteristic of silica prepared through sol–gel or similar methods [33]. This confirms that the SiO2 coating on the Fe2O3 nanoparticles is non-crystalline, forming an amorphous shell around the crystalline core. The coexistence of crystalline Fe2O3 and amorphous SiO2 phases validates the successful formation of Fe2O3@SiO2 core–shell nanoparticles. This core–shell structure not only enhances the material’s stability but also broadens its functional applications in areas such as catalysis, adsorption, and environmental remediation.

2.2.4. SEM-EDS Characterization

The SEM images, as shown in Figure 4a–f, provide a comparative morphological analysis of Fe2O3 and Fe2O3@SiO2 nanoparticles, offering insights into the uniformity and distribution of the nanoparticles, as well as the presence of agglomeration.
The SEM images presented show the morphology and surface structure of Fe2O3 and Fe2O3@SiO2 nanoparticles at different magnifications. Figure 4a shows Fe2O3 nanoparticles displaying an aggregated structure with irregularly shaped particles. The particles appear loosely packed, with a rough and uneven surface, indicating their potential for high surface reactivity. The particle size distribution varies, as seen from different scale bars (5 μm, 10 μm, and 20 μm), suggesting a heterogeneous morphology.
In contrast, Figure 4d–f represent Fe2O3@SiO2 nanoparticles, revealing a distinctly different structure. The presence of SiO2 coating is evident from the formation of a more structured and porous network. Figure 4d highlights the intricate porous structure with a well-defined texture, which could enhance the surface area and catalytic activity. Figure 4e further illustrates the hierarchical porosity, where layered formations and interconnected voids are visible, promoting better adsorption and reactant diffusion. Figure 4f provides an overall view of the Fe2O3@SiO2 composite, showing a dispersed, structured morphology with significantly reduced aggregation compared to pure Fe2O3 [34].
These structural transformations indicate that the SiO2 coating not only stabilizes Fe2O3 nanoparticles but also introduces hierarchical porosity, which is beneficial for the catalytic applications. The improved dispersion and increased surface area are expected to enhance the performance of Fe2O3@SiO2 nanoparticles in various chemical reactions.
The EDS (Energy-Dispersive Spectroscopy) analysis of Fe2O3@SiO2 nanoparticles, obtained through elemental mapping, confirms the presence of iron (Fe), oxygen (O), and silicon (Si) in the sample, indicating the successful synthesis of the composite. Iron was detected with a mass percentage of 25.95 ± 1.51% and an atomic percentage of 35.77 ± 2.08%, suggesting the presence of iron in Fe2O3 nanoparticles. Oxygen, with the highest atomic percentage of 47.81 ± 2.35% and a mass percentage of 46.20 ± 2.27%, highlights its critical role in the oxides (SiO2 and Fe2O3) and ensures the stability of the nanocomposite structure. Silicon, derived from the SiO2 shell, was observed with a mass percentage of 27.86 ± 1.42% and an atomic percentage of 16.42 ± 0.84%, confirming the effective coating of Fe2O3 nanoparticles. Also, based on the EDS data, the Fe2O3:SiO2 mass ratio is 0.6:1, indicating a higher proportion of SiO2 in the composite. The EDS data verify the successful incorporation of SiO2 into the composite and confirm the expected elemental composition, demonstrating the effectiveness of the synthesis process [29].

2.2.5. VSM Characterization

The magnetization hysteresis loop of both Fe2O3 as well as Fe2O3@SiO2 nanoparticles, as depicted in Figure 5, provides valuable insights into their magnetic behavior. The saturation magnetization (Ms) of Fe2O3 nanoparticles is 69.5 emu/g, reflecting their strong ferrimagnetic nature, which makes them suitable for applications requiring high magnetic responsiveness, such as magnetic separation and biomedical uses. However, upon coating with SiO2, the Ms of Fe2O3@SiO2 nanoparticles decreases significantly to 46.8 emu/g. This decrease is attributed to the non-magnetic nature of the SiO2 shell, which dilutes the overall magnetic moment of the composite. The SiO2 layer acts as a barrier, reducing the magnetic interaction between Fe2O3 particles and decreasing their effective magnetization [35].
Furthermore, the SiO2 coating enhances the stability of the nanoparticles by protecting the Fe2O3 core from oxidation and preventing agglomeration, which is a critical factor in maintaining their functional properties in various applications. Despite the reduction in Ms, the Fe2O3@SiO2 nanoparticles retain sufficient magnetic properties for practical use while gaining improved stability and dispersibility. This balance between reduced magnetization and enhanced functionality underscores the potential of Fe2O3@SiO2 nanoparticles in fields such as catalysis, environmental remediation, and biomedical applications.

2.3. Optimization of Conditions for Synthesis of Chalcone-Derived 1,4-Dihydropyridine Derivative

The chalcone-derived 1,4-DHPs derivatives were synthesized by condensation of an active methylene compound 4ae with a chalcone derivative 3ac in the presence of ammonium acetate 5, and the synthetic route to synthesize compounds 6ae, 7ae, and 8ae. A model condensation reaction was established to optimize the reaction conditions, containing a solution of chalcone 3ac (1 mmol), methyl-3-oxobutanoate 4a (1 mmol, 0.116 g), and NH4OAc 5 (1 mmol, 0.077 g) in 5 mL of ethanol, microwave-irradiated at 80 watts.

2.3.1. Optimization of Amount of Fe2O3@SiO2 Nanocatalyst

The effect of the Fe2O3@SiO2 nanocatalyst amount on the model reaction was thoroughly investigated to optimize the 1,4-DHPs derivatives synthesis (6a, 7a, and 8a) in terms of yield and reaction time. The results (Table 1) demonstrate that the nanocatalyst amount significantly impacts both the reaction rate and product yields. Without the catalyst (Entry 1), the reaction proceeded slowly, resulting in yields of 51%, 49%, and 54% for 6a, 7a, and 8a, respectively, after 10 min. When using pure Fe2O3 (Entry 6) as the catalyst at 3 mmol%, the reaction yielded 66%, 63%, and 62% for 6a, 7a, and 8a, respectively, in 10 min. While this demonstrates some catalytic activity, the lower yields compared to Fe2O3@SiO2 suggest that the SiO2 coating enhances catalytic efficiency, likely by improving dispersion, increasing surface area, or modifying the electronic environment of the active sites.
As the catalyst amount increased to 2 mmol% (Entry 3), yields further improved to 89%, 85%, and 87%, and the reaction time reduced to 7 min. The optimal performance was observed at 3 mmol% of the catalyst (Entry 4), where yields of 93%, 92%, and 94% were achieved in just 6 min. Increasing the catalyst amount to 4 mmol% (Entry 5) did not provide any significant improvement, with yields of 92%, 91%, and 94% matching closely with those at 3 mmol%.
However, increasing the catalyst loading to 5 mmol% (Entry 8) did not significantly enhance the yield but maintained a high conversion rate (92–93%), indicating that an excess of catalyst beyond a certain threshold does not provide substantial benefits. A comparison with Entries 5 and 6, where the catalyst amount remained at 3 mmol% but the reaction time was extended to 8 and 10 min, respectively, shows a gradual decline in yield. At 8 min (Entry 5), the yield dropped slightly (91% for 6a, 90% for 7a, and 91% for 8a), and at 10 min (Entry 6), a further decrease was observed (90% for 6a, 89% for 7a, and 90% for 8a).
These results highlight the importance of optimizing both catalyst loading and reaction time. While a longer reaction time generally allows for higher conversion, excessive durations may lead to secondary reactions or catalyst deactivation, slightly reducing the yield. Additionally, excessive catalyst amounts may not necessarily improve efficiency, as observed in Entry 8. Therefore, the best balance between reaction time and catalyst amount appears to be 3 mmol% Fe2O3@SiO2 with a reaction time of 6 min, ensuring high product yields with minimal reaction time [36].

2.3.2. Optimization of Solvent

The solvent plays a crucial role in the efficiency, yield, and reaction time of the condensation reaction catalyzed by 3 mmol% Fe2O3@SiO2 nanocatalyst for synthesizing 1,4-DHPs derivatives, i.e., 6a, 7a, and 8a. A range of solvents were assessed under standardized reaction conditions, and the results are summarized in Table 2. The choice of solvent significantly influences the efficiency, yield, and reaction time of the condensation reaction catalyzed by 3 mmol% Fe2O3@SiO2 nanocatalyst for synthesizing 1,4-DHPs derivatives (6a, 7a, and 8a). A variety of solvents (5 mL) were evaluated under standardized reaction conditions, and the findings are presented in Table 2.
Ethanol was identified as the optimal solvent (Table 2, Entry 6), delivering an exceptional yield of 94–95% within just 7 min. This superior performance can be attributed to ethanol’s excellent solvating ability, which enhances the dissolution of reactants and facilitates efficient molecular interactions [37]. Glycerol (Entry 5) also demonstrated high efficiency, yielding 90–91%, but required a longer reaction time of 15 min, possibly due to its higher viscosity, which may slow diffusion rates [38]. In the absence of a solvent (Entry 11), no product was obtained, likely due to poor reactant mobility and inadequate catalyst dispersion, which prevented effective interaction between the reacting species.
In contrast, solvents like methanol and acetonitrile provided moderate yields with longer reaction times (Entries 4 and 7), while water (Entry 3), DMSO (Entry 8), and DMF (Entry 9) were less effective, likely due to poor compatibility with the reactants or reduced catalytic activity in these media. These results highlight ethanol’s unique suitability for achieving high yields in minimal reaction time. Moreover, when the amount of ethanol was reduced from 5 mL to 1 mL, the reaction did not proceed, likely due to insufficient solubilization of the reactants and inadequate dispersion of the catalyst, which hindered proper interaction between the reacting species. This observation suggests that ethanol not only acts as a solvent but may also play a crucial role in stabilizing intermediates or enhancing the catalytic efficiency, making it the optimal choice for this transformation.

2.3.3. Optimization of Microwave Reactor Power

The influence of microwave power levels on the synthesis of 1,4-DHPs derivatives (6a, 7a, and 8a) was systematically investigated, and the results are presented in Table 3. The study demonstrates a clear relationship between power levels and reaction efficiency, particularly in terms of yield and reaction time. At lower power levels (75–85 W), the reaction proceeded more slowly, with yields reaching up to 92% at 85 W within 7 min (Table 3, Entry 3). This indicates that lower energy input is insufficient to maximize the interaction between reactants and the catalyst within a shorter time frame.
The maximum yield of 98% was achieved at 90 W in just 4 min (Table 3, Entry 4), highlighting this power level as the most efficient. The enhanced energy density at 90 W ensures optimal activation of reactants, leading to faster reaction rates and higher yields. However, increasing the power beyond 90 W (95–100 W) resulted in a slight decline in yield, with 96% and 93% recorded at 95 W and 100 W, respectively (Table 3, Entries 5 and 6). This reduction is likely due to the decomposition of intermediates or the product caused by excessive energy input.
Therefore, the optimal microwave power level for this reaction is identified as 90 W, which balances efficiency, yield, and reaction time. This demonstrates the importance of precise power control in microwave-assisted synthesis to achieve maximum product efficiency.

2.3.4. Reusability of Fe2O3@SiO2 Nanocatalyst

The reusability study of the Fe2O3@SiO2 nanocatalyst under optimized conditions confirmed its exceptional stability and efficiency, with consistently high product yields over four consecutive cycles, as shown in Table 4. The fresh catalyst achieved a yield of 98%, which gradually decreased to 95% by the fourth run. This minor reduction in catalytic activity can be attributed to the potential loss of active sites due to minor leaching of the catalyst or the accumulation of by-products on the surface during repeated use.
This stability is attributed to the robust structure of the nanocatalyst, where SiO2 provides a protective framework for Fe2O3, ensuring its active sites remain effective. The marginal decline in yield may result from minor physical wear or loss of catalyst during recovery and washing. The excellent recyclability of the nanocatalyst enhances the economic viability and aligns with sustainable green chemistry practices, making it a practical choice for repeated use in organic synthesis.

2.4. Characterization of Methyl-2-methyl-4,6-diphenyl-1,4-dihydropyridine-3-carboxylate (6a)

The compound methyl 2-methyl-4,6-diphenyl-1,4-dihydropyridine-3-carboxylate (6a) was obtained as a white crystalline solid with a melting point of 156–157 °C. In its IR spectrum, the broad peak at 3441 cm−1 indicates N-H stretching, confirming the presence of a secondary amine group. The aromatic C-H stretching vibrations appear at 3106 cm−1, while the methyl C-H stretching is observed at 2943 cm−1. A sharp band at 3031 cm−1 suggested the presence of a carboxyl group (-COOH). The strong band at 1668 cm−1 corresponds to the carbonyl (C=O) stretching, which is characteristic of an ester group. The C=C stretching vibrations of the aromatic ring are observed at 1595 cm−1. Additionally, peaks at 1206 cm−1 and 1081 cm−1 are associated with C-O stretching, indicating the presence of ester and methoxy groups. These spectral features collectively confirm the structural integrity and functional groups of the synthesized compound.
The 1H NMR spectrum, the aromatic region displays two sets of signals corresponding to the phenyl rings. The multiplet at δ 8.01–7.47 ppm (10H) is attributed to the protons of two phenyl rings. The singlet at δ 11.13 ppm (1H) is due to the N-H proton of the dihydropyridine ring. The protons of the dihydropyridine ring resonate at δ 4.72–4.71 ppm (1H) and δ 4.35–4.32 ppm (1H), reflecting the fact that they are chemically and magnetically inequivalent. The methoxy group appears as a singlet at δ 3.54 ppm (3H), while the methyl group attached to the dihydropyridine ring is observed as a singlet at δ 2.26 ppm (3H).
In the 13C NMR spectrum, the carbonyl carbon of the ester group resonates at δ 173.2 ppm, confirming the presence of the C=O functional group. The aromatic carbons are distributed over several peaks, with δ 151.6 ppm corresponding to C-2 (of the dihydropyridine ring), and δ 142.4 ppm and δ 141.7 ppm representing C-1’ and C-6, respectively. The remaining aromatic carbons appear between δ 135.1 ppm and δ 126.4 ppm, corresponding to the phenyl rings. The C=C bond of the dihydropyridine ring resonates at δ 124.9 ppm. The C-3 and C-5 carbons of the dihydropyridine ring are observed at δ 106.8 ppm and δ 94.5 ppm, respectively, while C-4 resonates at δ 47.6 ppm. The methoxy group carbon (COOCH3) is evident at δ 55.1 ppm, and the methyl carbon (CH3) attached to the dihydropyridine ring appears at δ 19.2 ppm. These data collectively validate the successful synthesis and characterization of compound 6a. The mass spectrum displayed a molecular ion peak at m/z 306 [M + 1], consistent with the molecular formula C20H19NO2. Elemental analysis also supported the compound’s composition, with calculated and observed values closely matching for carbon, hydrogen, and nitrogen. These data collectively validate the successful synthesis and characterization of compound 6a.
Table 5 provides an overview of the synthesis and characterization of chalcone-derived 1,4-dihydropyridine derivatives (6ae, 7ae, and 8ae), detailing their reaction times, yields, and melting points.
Figure 6 illustrates the structures of chalcones and chalcone-derived 1,4-dihydropyridine derivatives (6ae, 7ae, 8ae), highlighting their key modifications. All these derivatives were synthesized efficiently with reaction times ranging between 3 and 5 min and yields exceeding 90%, showcasing the effectiveness of the method. The observed melting points closely align with the reported literature values, confirming the successful synthesis and high purity of the compounds. These results underscore the reproducibility and efficiency of the synthetic approach employed for these derivatives.

2.5. Plausible Mechanism for Synthesis of Chalcone-Derived 1,4-Dihydropyridine Derivatives

The synthesis of chalcone-derived 1,4-dihydropyridine derivatives, using Fe2O3@SiO2 as a nanocatalyst, follows a series of well-defined steps that are catalytically enhanced by the Fe2O3@SiO2 nanomaterial. This core–shell nanocatalyst accelerates the reaction by providing active sites for adsorption and activation of reactants, facilitating electron transfer, and stabilizing key intermediates [39]. The Fe2O3 core, known for its Lewis acidity, facilitates the activation of the chalcone carbonyl group by coordinating with oxygen and stabilizing key intermediates, thereby enhancing the reaction efficiency. The SiO2 shell prevents nanoparticle aggregation and maintains consistent catalytic activity, ensuring that the catalysts can be reused for multiple cycles [40]. The Fe2O3@SiO2 nanocatalyst provides a large surface area for the adsorption and activation of the chalcone 3 and active methylene compound, 4. The iron oxide core facilitates electron transfer, enhancing the electrophilicity of the chalcone carbonyl group. Their surface contains active sites that facilitate the activation of reactants and intermediates by coordinating with functional groups [41].
Ammonium acetate 5 reacts with the β-ketoester 4 in the presence of magnetic nanoparticles. The nanoparticles likely activate the carbonyl group of the β-ketoester, making it more electrophilic [42]. Ammonium acetate donates ammonia, which undergoes nucleophilic attack to form an enamine intermediate I, as shown in Scheme 1. The chalcone (α, β-unsaturated ketone) reacts with the enamine intermediate I. Magnetic nanoparticles stabilize this reaction by activating the electrophilic β-carbon of the chalcone 3 [43]. The nucleophilic enamine attacks this β-carbon, leading to a Michael-type addition and forming a new intermediate II. The intermediate undergoes intramolecular cyclization. The carbonyl oxygen from the β-ketoester forms a bond with the nearby nucleophilic amine group. The magnetic nanoparticles assist in this step by stabilizing the transition state, ensuring smooth cyclization.
The magnetic nanoparticles further catalyze the dehydration process, facilitating the removal of a water molecule, thereby driving the reaction to completion and yielding the final product. Magnetic nanoparticles ensure high selectivity and efficiency by stabilizing reactive intermediates throughout the process [44].
This mechanism highlights the synergistic role of the Fe2O3@SiO2 nanocatalyst, where the Fe2O3 core drives electron transfer and redox processes, while the SiO2 shell ensures catalyst stability and high efficiency throughout the reaction. The reaction under these conditions offers a green and efficient method for synthesizing chalcone-derived 1,4-dihydropyridine derivatives [45].

2.6. Antimicrobial Activity

The antimicrobial activity of the synthesized compounds (6ae, 7ae, and 8ae) was evaluated against selected microbial strains using the Minimum Inhibitory Concentration (MIC) method, with the results summarized in Table 6. The standard drugs, Fluconazole and Amoxicillin, served as references, showing MIC values of 4 μg/mL and 2 μg/mL, respectively. As evident from Table 6, the 8ae series demonstrated excellent resistance against all the bacterial and fungal strains compared to the 6ae and 7ae series. The enhanced activity of the 8ae series can be attributed to the presence of polar groups such as -OCH3 on the aromatic rings, which facilitate hydrogen bonds with microbial proteins. Their effectiveness was comparable to that of the standard drugs, Amoxicillin (MIC 4 μg/mL) and Fluconazole (MIC 2 μg/mL).
Furthermore, the fusion of the 1,4-DHP ring with heterocyclic rings demonstrated excellent resistance against the tested microbes. The combined influence of polar groups and fusion with heterocyclic moieties enabled compound 8c to demonstrate remarkable resistance against all the tested strains, matching the MIC values of the standard drugs. Conversely, due to the absence of both conditions, the chalcone-derived 1,4-DHPs derivatives 6a, 6b, and 6e were found to be the least active against the tested strains.

3. Materials and Methods

3.1. Reagents and Instruments

The chemicals used in this study were sourced from Sigma-Aldrich (Chandigarh, India) and Merck (Chandigarh, India). All solvents were of analytical grade, were purchased from TCI (Chandigarh, India), and were used without further purification. The Ammonia solution (25% purity) was sourced from Loba Chemie (Chandigarh, India). Ultrapure deionized water was used consistently throughout the experiments, and the stock solutions for all assays were prepared using this water.
The Fourier Transform Infrared (FT-IR) spectra of the nanoparticles were recorded using an ATR mode on a Perkin Elmer Spectrum II spectrometer at Chandigarh University, Punjab, India, in the 400–4000 cm−1 range. The morphology of the nanoparticles was analyzed with a field emission scanning electron microscope (JSM IT500) at 10 kV. The elemental analysis of nanocatalyst was performed using Energy-Dispersive X-ray Spectroscopy (EDS) at UCRD Department, Chandigarh University, Punjab, India. The X-ray diffraction (XRD) patterns of the dried samples were obtained using a Bruker (Chandigarh University, Punjab, India) D8 Advanced diffractometer. Magnetic properties were assessed using a Lake Shore (IIT Roorkee, India) 7410 vibrating sample magnetometer (VSM). The chalcone-derived 1,4-dihydropyridine derivatives were synthesized using Anton Paar (Chandigarh University, Punjab, India) microwave reactor (Monowave 200) under optimized conditions (Chandigarh University, Punjab, India). The DLS and Zeta-potential was performed using a Malvern-Zetasizer Lab blue-ZSU3100 instrument in UCRD Department, Chandigarh University. The 1H NMR and 13C NMR spectra were obtained using a Bruker Avance NEO 500 MHz NMR spectrometer (Punjab University, Chandigarh, India), with CDCl3 used as the solvent. The melting points of the synthesized products were determined using a digital melting point apparatus, following the open capillary method.

3.2. Synthesis of Fe2O3@SiO2 Nanocatalyst

3.2.1. Synthesis of Magnetic Fe2O3 Nanoparticles

The Fe2O3 nanoparticles were synthesized following the procedure outlined in our previous study using the co-precipitation method [46]. In brief, 12 g of FeCl3 and 6 g of FeSO4·7H2O were dissolved in 100 mL of deionized water. The mixture was purged with N2 gas and stirred for one hour. Ammonia solution (25%) was then added dropwise, and the pH was adjusted to approximately 10 with 2.0 M NaOH. The mixture was heated to 70 °C, with continuous stirring and N2 gas purging for 5 h, which resulted in the formation of a black precipitate. The precipitate was filtered, washed with acetone, and rinsed with deionized water until the pH was neutral. Finally, the resulting Fe2O3 nanoparticles were dried at 60 °C in a vacuum oven.

3.2.2. Fabrication of Magnetic Fe2O3 Nanoparticles with SiO2

For the SiO2 coating, 3 g of tetraethyl orthosilicate (TEOS) was dissolved in 50 mL of ethanol, and 1 mL of ammonium hydroxide was added to initiate hydrolysis. The Fe2O3 nanoparticles (2 g) were then dispersed in 100 mL of ethanol, and the prepared SiO2 sol was added under stirring. The mixture was stirred for 4 h, filtered, washed with ethanol, and dried at 60 °C to obtain the Fe2O3@SiO2 nanoparticles.

3.3. General Procedure for Claisen–Schmidt Condensation for Synthesis of Chalcone Derivatives

Chalcones were prepared through a Claisen–Schmidt condensation reaction, involving the reaction between acetophenone and various aldehydes under basic conditions, as illustrated in Scheme 2.
In this study, aldehyde derivatives 1ac (1 mmol) were reacted with acetophenone 2 (1 mmol, 0.120 g) in 15 mL of ethanol in a 50 mL round-bottom flask. A 10 mL solution of potassium hydroxide (0.1 g in 10 mL distilled water) was added dropwise to the mixture over 30 min with continuous stirring. The reaction was conducted at a temperature of 0–5 °C, maintained using an ice bath on a magnetic stirrer. The reaction was stirred vigorously for 4–5 h. After completion, the reaction was neutralized with 1N HCl, resulting in the precipitation of the chalcone product. The crude product was filtered, air-dried, and recrystallized from ethanol. Further purification was achieved through column chromatography on alumina, using a 10% ethyl acetate in hexane mixture as the eluent, to yield pure chalcones 3ac. The progress of the reaction and the purity of chalcones were monitored using TLC on silica gel 60 F254 plates with a hexane–ethyl acetate solvent system (7:3, v/v) solvent system. The spectroscopic data (FT-IR, 1H & 13C NMR) and melting point of the synthesized compounds matched the values reported in the literature [47]. The characterization data of chalcone derivatives are provided below:
  • (E)-1,3-diphenylprop-2-en-1-one (3a): Yield 94%, 0.196 g, White crystalline solid, mp 56–57 °C. IR spectrum, υ, cm−1: 3077, 3026 (aromatic C-H), 2926, 2868 (methylene C-H), 1662 (C=O), 1595 (C=C), 1206, 1076, (C-O). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 8.03–7.41 (12H, m, Ar-H). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 190.6, 144.8, 138.2, 134.9, 132.8, 130.5, 128.9, 128.6, 128.5, 128.4, 122.1. Mass spectrum, m/z: 209 [M + 1]. Anal. calcd. for C15H12O: C, 86.51; H, 5.81. Found: C, 86.39; H, 5.73.
  • (E)-3-(3-nitrophenyl)-1-phenylprop-2-en-1-one (3b): Yield 89%, 0.226 g, Lime yellow crystalline solid, mp 143–145 °C. IR spectrum, υ, cm−1: 3088, 3071 (aromatic C-H), 2871 (methylene C-H), 1659, 1593, 1526, 1349, 1217, 1080. 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 8.51–7.52 (11H, m, Ar-H). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 189.6, 148.7, 141.6, 137.6, 136.6, 134.3, 133.3, 130.0, 128.8, 128.7, 128.6, 124.6, 122.3. Mass spectrum, m/z: 254 [M + 1]. Anal. calcd. for C15H11NO3: C, 71.14; H, 4.38; N, 5.59. Found: C, 71.10; H, 4.27; N, 5.56.
  • (E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one (3c): Yield 84%, 0.214 g, White crystalline solid, mp 185–187 °C. IR spectrum, υ, cm−1 (CDCl3, 500 MHz): 3126 (O-H), 2973 (aromatic C-H), 2842 (methylene C-H), 1644 (C=O), 1595 (C=C), 1206, 1076, (C-O). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 8.02–6.93 (11H, m, Ar-H), 3.88 (3H, s, OCH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 189.9, 164.5, 159.6, 144.0, 131.0, 130.1, 127.5, 119.5, 115.3, 114.4, 55.42. Mass spectrum, m/z: 255 [M + 1]. Anal. calcd. for C16H14O3: C, 75.57; H, 5.59. Found: C, 75.49; H, 5.51.

3.4. General Procedure for the Synthesis of 1,4-Dihydropyridine Derivatives from Chalcones Using Fe2O3@SiO2 Nanocatalyst

Under the optimized experimental conditions, a mixture of chalcone 3ac (1 mmol), active methylene group 4ae (1 mmol), and ammonium acetate 5 (1 mmol), were dissolved in 5 mL of ethanol and irradiated at 90 watts for 4 min in a sealed tube using a microwave reactor (Scheme 3). The reaction was conducted in the presence of 3 mmol% Fe2O3@SiO2 as a nanocatalyst.
After the reaction was complete, the mixture was cooled and subjected to a workup process. The residue was extracted by portioning between 25 mL of distilled water and 25 mL of dichloromethane. The aqueous layer was then extracted with dichloromethane (2 × 10 mL). The combined organic extracts were dried over anhydrous sodium sulfate, then concentrated under reduced pressure using a rotary evaporator. The resulting product was purified to obtain the desired compound. The reaction progress and purity of the synthesized 1,4-dihydropyridine derivatives were monitored using TLC on silica gel 60 F254 plates with a hexane–ethyl acetate solvent system (6:4, v/v) solvent system. The spectroscopic data (FT-IR, 1H & 13C NMR) and melting point of the synthesized compounds agreed with those reported in the literature [13,20,28].
  • Methyl 2-methyl-4,6-diphenyl-1,4-dihydropyridine-3-carboxylate (6a): Yield 94%, 0.287 g, White crystalline solid, mp 156–157 °C. IR spectrum, υ, cm−1: 3441 (N-H), 3106 (aromatic C-H), 3031 (COOH), 2943 (methyl C-H), 1668 (C=O), 1595 (C=C), 1206, 1081, (C-O). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.13 (1H, s, NH), 8.01–7.47 (10H, m, Ar-H), 4.72–4.71 (1H, H-5), 4.35–4.32 (1H, H-4), 3.54 (3H, s, COOCH3), 2.26 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 173.2, 151.6, 142.4, 141.7, 135.1, 129.6, 128.8, 128.1, 127.2, 126.4, 124.9, 106.8, 94.5, 55.1, 47.6, 19.2. Mass spectrum, m/z: 306 [M + 1]. Anal. calcd. for C20H19NO2: C, 78.66; H, 6.27: N, 4.59. Found: C, 78.59; H, 6.22: N, 4.56.
  • 1-(2-methyl-4,6-diphenyl-1,4-dihydropyridin-3-yl)ethenone (6b): Yield 92%, 0.281 g, White crystalline solid, mp 164–166 °C. IR spectrum, υ, cm−1: 3452 (N-H), 3096, 3078 (aromatic C-H), 2926, 2868 (methylene C-H), 1661 (C=O), 1615 (C=C). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.17 (1H, s, NH), 7.84–7.27 (10H, m, Ar-H), 4.88–4.86 (1H, H-5), 4.63–4.61 (1H, H-4), 2.47 (3H, s, COCH3), 1.90 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 194.8, 153.1, 143.0, 141.1, 134.8, 129.8, 129.2, 128.7, 128.1, 127.5, 126.0, 112.9, 96.1, 42.3, 29.7, 18.8. Mass spectrum, m/z: 290 [M + 1]. Anal. calcd. for C20H19NO: C, 83.01; H, 6.62: N, 4.84. Found: C, 82.97; H, 6.53: N, 4.81.
  • 5,7-diphenylpyrido[2,3-d]pyrimidine-2,4(1H,3H,5H,8H)-dione (6c): Yield 96%, 0.295 g, Pale crystalline solid, mp 271–272 °C. IR spectrum, υ, cm−1: 3449 (N-H), 3086, 3023 (aromatic C-H), 2912 (methylene C-H), 1696 (C=O), 1589 (C=C), 1462 (C-N). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.15 (1H, s, NH), 10.0 (1H, s, NH), 7.89 (1H, s, NH), 7.65–7.17 (10H, m, Ar-H), 4.86–4.84 (1H, H-5), 4.70–4.68 (1H, H-4). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 167.3, 155.8, 152.8, 142.8, 141.3, 135.2, 129.6, 129.0, 128.7, 128.1, 127.2, 125.9, 94.9, 82.3, 43.7. Mass spectrum, m/z: 318 [M + 1]. Anal. calcd. for C19H15N3O2: C, 71.91; H, 4.76: N, 13.24. Found: C, 71.88; H, 4.70: N, 13.20.
  • 1,3-dimethyl-5,7-diphenylpyrido[2,3-d]pyrimidine-2,4(1H,3H,5H,8H)-dione (6d): Yield 93%, 0.345 g, Pale crystalline solid, mp 263–265 °C. IR spectrum, υ, cm−1: 3465 (N-H), 3087, 3063 (aromatic C-H), 2983, 2920 (methylene C-H), 1682 (C=O), 1597 (C=C), 1454 (C-N). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.10 (1H, s, NH), 7.69–7.24 (10H, m, Ar-H), 4.86–4.84 (1H, H-5), 4.57–4.55 (1H, H-4), 2.90 (3H, s, CH3), 2.83 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 165.9, 153.2, 149.6, 142.5, 140.8, 135.1, 129.7, 129.3, 128.6, 128.0, 126.4, 125.7, 92.6, 80.9, 42.8, 32.4, 29.9. Mass spectrum, m/z: 346 [M + 1]. Anal. calcd. for C21H19N3O2: C, 73.03; H, 5.54; N, 12.1. Found: C, 72.95; H, 5.48; N, 11.9.
  • 2-nitro-4,6-diphenyl-1,4-dihydropyridine-3-carbonitrile (6e): Yield 95%, 0.335 g, White crystalline solid, mp 219–222 °C. IR spectrum, υ, cm−1: 3441 (N-H), 3078, 3061 (aromatic C-H), 2869 (methylene C-H), 2250 (C≡N), 1597 (C=C). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.21 (1H, s, NH), 7.75–7.19 (10H, m, Ar-H), 6.59 (s, 1H, NH2), 4.83–4.81 (1H, H-5), 4.60–4.58 (1H, H-4). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 191.6, 148.5, 142.2, 140.0, 133.6, 129.6, 128.9, 128.3, 127.8, 126.0, 125.2, 102.7, 91.6, 41.8. Mass spectrum, m/z: 336 [M + 1]. Anal. calcd. for C24H17NO: C, 85.94; H, 5.11: N, 4.18. Found: C, 85.90; H, 5.02: N, 4.16.
  • Methyl 2-methyl-4-(3-nitrophenyl)-6-phenyl-1,4-dihydropyridine-3-carboxylate (7a): Yield 94%, 0.350 g, Lemon crystalline solid, mp 133–134 °C. IR spectrum, υ, cm−1: 3436 (N-H), 3101 (aromatic C-H), 3045 (COOH), 2951 (methyl C-H), 1667 (C=O), 1648 (N-O), 1590 (C=C), 1202, (C-O). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.33 (1H, s, NH), 7.80–7.12 (9H, m, Ar-H), 4.69–4.68 (1H, d, H-5), 4.29–4.27 (1H, H-4), 3.55 (3H, s, COOCH3), 2.36 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 172.3, 152.1, 148.4, 145.9, 142.4, 135.2, 133.7, 129.8, 128.8, 128.2, 124.1, 122.9, 120.7, 105.2, 93.3, 54.7, 46.3, 18.8. Mass spectrum, m/z: 351 [M + 1]. Anal. calcd. for C20H18N2O4: C, 68.56; H, 5.18: N, 8.00. Found: C, 68.50; H, 5.12: N, 7.98.
  • 1-(2-methyl-4-(3-nitrophenyl)-6-phenyl-1,4-dihydropyridin-3-yl)ethenone (7b): Yield 97%, 0.334 g, Lemon crystalline solid, mp 151–153 °C. IR spectrum, υ, cm−1: 3447 (N-H), 3091, 3083 (aromatic C-H), 2931, 2883 (methylene C-H), 1656 (C=O), 1640 (N-O), 1611 (C=C). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.12 (1H, s, NH), 7.92–7.23 (9H, m, Ar-H), 4.88–4.86 (1H, d, H-5), 4.57–4.55 (1H, H-4), 2.40 (3H, s, COCH3), 1.78 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 193.5, 150.3, 148.2, 144.8, 142.3, 135.9, 134.6, 130.6, 129.6, 128.4, 126.3, 123.7, 118.9, 110.3, 94.8, 43.3, 28.1, 16.7. Mass spectrum, m/z: 335 [M + 1]. Anal. calcd. for C20H18N2O3: C, 71.84; H, 5.43: N, 8.38. Found: C, 71.77; H, 5.40: N, 8.34.
  • 5-(3-nitrophenyl)-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H,5H,8H)-dione (7c): Yield 92%, 0.314 g, Pale crystalline solid, mp 239–241 °C. IR spectrum, υ, cm−1: 3425 (N-H), 3092, 3044 (aromatic C-H), 2903 (methylene C-H), 1682 (C=O), 1591 (C=C), 1478 (C-N). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.11 (1H, s, NH), 10.25 (1H, s, NH), 8.56 (1H, s, NH), 8.01–7.32 (9H, m, Ar-H), 4.80–4.78 (1H, H-5), 4.62–4.60 (1H, H-4). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 166.2, 154.1, 151.4, 148.3, 144.5, 142.2, 134.6, 136.8, 129.7, 128.9, 127.6, 126.1, 123.6, 119.6, 91.8, 80.9, 42.4. Mass spectrum, m/z: 363 [M + 1]. Anal. calcd. for C15H14N4O4: C, 62.98; H, 3.89: N, 15.46. Found: C, 62.91; H, 3.78: N, 15.43.
  • 1,3-dimethyl-5-(3-nitrophenyl)-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H,5H,8H)-dione (7d): Yield 91%, 0.391 g, Pale crystalline solid, mp 236–238 °C. IR spectrum, υ, cm−1: 3451 (N-H), 3084, 3057 (aromatic C-H), 2978, 2926 (methylene C-H), 1688 (C=O), 1639 (N-O), 1590 (C=C), 1447 (C-N). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.14 (1H, s, NH), 7.95–7.42 (9H, m, Ar-H), 4.79–4.77 (1H, H-5), 4.57–4.56 (1H, H-4), 2.94 (3H, s, CH3), 2.91 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 166.1, 152.7, 149.3, 148.0, 144.4, 141.1, 136.4, 134.8, 130.2, 129.4, 122.9, 128.1, 125.7, 122.9, 120.2, 92.8, 81.3, 42.4, 32.1, 29.5. Mass spectrum, m/z: 391 [M + 1]. Anal. calcd. for C21H18N4O4: C, 64.61; H, 4.65: N, 14.35. Found: C, 64.54; H, 4.58: N, 14.30.
  • 2-nitro-4-(3-nitrophenyl)-6-phenyl-1,4-dihydropyridine-3-carbonitrile (7e): Yield 94%, 0.381 g, Lemon crystalline solid, mp 208–210 °C. IR spectrum, υ, cm−1: 3423 (N-H), 3081, 3057 (aromatic C-H), 2853 (methylene C-H), 1714 (C=O), 2251.3 (C≡N), 1589 (C=C). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.22 (1H, s, NH), 7.95–7.14 (9H, m, Ar-H), 6.89 (s, 1H, NH2), 4.78–4.76 (1H, H-5), 4.61–4.59 (1H, H-4). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 190.9, 148.7, 147.1, 143.7, 141.2, 136.1, 135.3, 129.6, 128.2, 129.4, 119.5, 127.8, 125.7, 123.8, 105.0, 92.3, 40.3. Mass spectrum, m/z: 381 [M + 1]. Anal. calcd. for C24H16N2O3: C, 75.78; H, 4.24: N, 7.36. Found: C, 75.71; H, 4.17: N, 7.32.
  • Methyl 4-(4-methoxyphenyl)-2-methyl-6-phenyl-1,4-dihydropyridine-3-carboxylate (8a): Yield 90%, 0.336 g, White crystalline solid, mp 172–173 °C. IR spectrum, υ, cm−1: 3434 (N-H), 3102 (aromatic C-H), 3038 (COOH), 2940 (methyl C-H), 1657 (C=O), 1650 (N-O), 1591 (C=C), 1211, 1093, (C-O). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.13 (1H, s, NH), 8.01–7.47 (9H, m, Ar-H), 4.73–4.71 (1H, d, H-5), 4.35–4.432 (1H, d, H-4), 3.54 (3H, s, OCH3), 2.51 (3H, s, COOCH3), 2.26 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 169.8, 157.6, 155.9, 150.4, 141.2, 135.0, 131.7, 127.9, 126.7, 117.3, 115.1, 105.8, 92.1, 56.6, 51.3, 17.5. Mass spectrum, m/z: 336 [M + 1]. Anal. calcd. for C21H21NO3: C, 71.78; H, 5.02: N, 3.99. Found: C, 71.69; H, 4.95: N, 3.94.
  • 1-(4-(4-hydroxyphenyl)-2-methyl-6-phenyl-1,4-dihydropyridin-3-yl)ethenone (8b): Yield 93%, 0.320 g, White crystalline solid, mp 187–188 °C. IR spectrum, υ, cm−1: 3452 (N-H), 3090, 3074 (aromatic C-H), 2922, 2873 (methylene C-H), 1664 (C=O), 1645 (N-O), 1622 (C=C). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.13 (1H, s, NH), 7.20–6.61 (9H, m, Ar-H), 4.78–4.76 (1H, d, Hz, H-5), 4.42–4.40 (1H, H-4), 3.69 (3H, s, OCH3), 2.23 (3H, s, OCH3), 1.81 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 197.2, 157.8, 156.1, 149.7, 140.9, 135.6, 130.7, 128.2, 127.0, 116.5, 114.8, 113.6, 93.4, 57.1, 42.7, 28.5, 16.8. Mass spectrum, m/z: 320 [M + 1]. Anal. calcd. for C21H21NO2: C, 75.20; H, 6.31: N, 4.18. Found: C, 75.16; H, 6.24: N, 4.15.
  • 5-(4-methoxyphenyl)-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H,5H,8H)-dione (8c): Yield 95%, 0.348 g, Lemon crystalline solid, mp 286–288 °C. IR spectrum, υ, cm−1: 3440 (N-H), 3082, 3027 (aromatic C-H), 2919 (methylene C-H), 1691 (C=O), 1583 (C=C), 1455 (C-N). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.02 (1H, s, NH), 8.47 (1H, s, NH), 7.87 (1H, s, NH), 7.21–6.63 (9H, m, Ar-H), 4.82–4.80 (1H, H-5), 4.58–4.56 (1H, H-4), 3.74 (3H, s, OCH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 164.9, 157.0, 155.2, 153.4, 151.7, 141.4, 135.8, 130.6, 127.9, 126.2, 117.1, 115.7, 93.0, 79.9, 56.7, 41.2. Mass spectrum, m/z: 348 [M + 1]. Anal. calcd. for C20H17N3O3: C, 66.11; H, 4.72: N, 11.56. Found: C, 66.03; H, 4.67: N, 11.51.
  • 5-(4-methoxyphenyl)-1,3-dimethyl-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H,5H,8H)-dione (8d): Yield 96%, 0.376 g, Lemon crystalline solid, mp 289–291 °C. IR spectrum, υ, cm−1: 3452 (N-H), 3092, 3056 (aromatic C-H), 2971, 2934 (methylene C-H), 1685 (C=O), 1590 (C=C), 1448 (C-N). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.16 (1H, s, NH), 7.15–6.69 (9H, m, Ar-H), 4.74–4.72 (1H, H-5), 4.50–4.48 (1H, H-4), 3.67 (3H, s, OCH3), 2.85 (3H, s, CH3), 2.80 (3H, s, CH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 163.5, 157.8, 156.7, 152.0, 148.4, 140.9, 134.7, 132.4, 129.8, 127.3, 116.6, 113.7, 92.3, 80.4, 56.2, 41.6, 31.6, 28.9. Mass spectrum, m/z: 375 [M + 1]. Anal. calcd. for C22H21N3O3: C, 67.51; H, 5.41: N, 10.74. Found: C, 67.43; H, 5.34: N, 10.68.
  • 4-(4-methoxyphenyl)-2-nitro-6-phenyl-1,4-dihydropyridine-3-carbonitrile (8e): Yield 93%, 0.333 g, White crystalline solid, mp 235–237 °C. IR spectrum, υ, cm−1: 3437 (N-H), 3082, 3066 (aromatic C-H), 2863 (methylene C-H), 2251.6 (C≡N), 1592 (C=C). 1H NMR spectrum, δ, ppm (CDCl3, 500 MHz): 11.25 (1H, s, NH), 7.18–6.62 (9H, m, Ar-H), 6.89 (s, 1H, NH2), 4.82–4.80 (1H, H-5), 4.59–4.57 (1H, H-4), 3.51 (3H, s, OCH3). 13C NMR spectrum, δ, ppm (CDCl3, 125 MHz): 193.1, 158.4, 157.1, 146.7, 141.2, 143.7, 141.2, 135.6, 131.3, 128.0, 126.5, 116.1, 114.4, 101.9, 94.1, 55.6, 41.2. Mass spectrum, m/z: 334 [M + 1]. Anal. calcd. for C19H15N3O3: C, 78.72; H, 5.02: N, 3.67. Found: C, 78.65; H, 4.95: N, 3.62.

3.5. Antimicrobial Activity

The newly synthesized chalcone-derived 1,4-dihydropyridine derivatives 6ae, 7ae, and 8ae were evaluated for their antimicrobial properties against a broad spectrum of microorganisms. The study included two Gram-positive bacterial strains, Streptococcus pyogenes (MTCC 442) and Bacillus subtilis (MTCC 441); three Gram-negative bacterial strains, Klebsiella pneumoniae (MTCC 3384), Escherichia coli (MTCC 443), and Staphylococcus aureus (MTCC 96); as well as three fungal strains, Aspergillus niger (MTCC 281), Aspergillus janus (MTCC 2751), and Aspergillus sclerotiorum (MTCC 1008). The fungal strains were cultured in malt extract medium at 28 °C for 72 h to ensure optimal growth, while the bacterial strains were incubated in nutrient broth at 37 °C for 24 h. The antimicrobial activity of the synthesized derivatives was evaluated by preparing serial dilutions of each compound in DMSO, with concentrations ranging from 2 to 128 µg/mL. The compounds were tested in triplicate to ensure the reliability of the results, using a standard disc diffusion method to assess their inhibition zones against each microorganism. The results of this comprehensive screening provide insights into the potential antimicrobial efficacy of these chalcone-derived 1,4-dihydropyridine derivatives, offering a promising avenue for the development of antimicrobial agents.

4. Conclusions

In conclusion, this study successfully synthesized chalcone-derived 1,4-DHPs derivatives using Fe2O3@SiO2 nanoparticles as an efficient and recyclable nanocatalyst. The XRD analysis confirmed the crystalline Fe2O3 and amorphous SiO2 phases. The DLS analysis concludes that the silica coating on Fe2O3 nanoparticles increases the hydrodynamic diameter from 12 nm to 18 nm while improving particle uniformity, as evidenced by the reduction in PDI from 0.34 to 0.22, making Fe2O3@SiO2 more suitable for applications requiring consistent size and distribution. The synthesized chalcone-derived 1,4-DHPs derivatives showed excellent yields under optimized conditions, with the microwave-assisted method significantly enhancing the efficiency. Antimicrobial testing revealed that series 8ae, especially compound 8c, demonstrated remarkable activity against bacterial and fungal strains. The MIC values for 8c against S. aureus, E. faecalis, and C. albicans were 12.5 µg/mL, comparable to those of standard drugs such as Amoxicillin (4 µg/mL) and Fluconazole (2 µg/mL). Other derivatives showed moderate activity, with MIC values ranging from 25 to 50 µg/mL, but no significant activity was observed against Gram-negative bacteria at ≥100 µg/mL. These findings suggest that Fe2O3@SiO2 nanoparticles are an effective catalyst for the synthesis of bioactive molecules, offering a greener and more sustainable alternative to traditional catalytic methods.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/catal15030281/s1, Scheme S1. Synthesis of chalcone derivatives 3ac by Claisen-Schmidt condensation; Scheme S2. Synthesis of 1,4-dihydropyridine derivatives catalyzed by Fe2O3@SiO2 nanocatalyst; Scheme S3. The chalcone-derived 1,4-dihydropyridine derivative (6ae, 7ae, 8ae) library; Figure S1. 1H NMR spectrum of chalcone (3a); Figure S2. 1H NMR spectrum of (E)-3-(3-nitrophenyl)-1-phenylprop-2-en-1-one (3b); Figure S3. 1H NMR spectrum of (E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one (3c); Figure S4. 1H NMR spectrum of Methyl 2-methyl-4,6-diphenyl-1,4-dihydropyridine-3-carboxylate (6a); Figure S5. 1H NMR spectrum of Methyl 2-methyl-4-(3-nitrophenyl)-6-phenyl-1,4-dihydropyridine-3-carboxylate (7a); Figure S6. 1H NMR spectrum of Methyl 4-(4-methoxyphenyl)-2-methyl-6-phenyl-1,4-dihydropyridine-3-carboxylate (8a).

Author Contributions

Writing—original draft, D.S.M. and H.S.S.; investigation, H.H. and P.K.B.; conceptualization, M.K. and M.V.; methodology, H.S.S.; funding acquisition, F.M.H.; writing—review and editing, H.H., D.S.M. and N.K.; supervision, H.S.S. All authors have read and agreed to the published version of the manuscript.

Funding

The authors thank the Researchers Supporting Project Number (RSPD2025R729), King Saud University, Riyadh, Saudi Arabia.

Data Availability Statement

All data generated or analyzed during this study are included in this published article (and its Supplementary Materials).

Acknowledgments

The authors thank the Researchers Supporting Project Number (RSPD2025R729), King Saud University, Riyadh, Saudi Arabia. H.H. sincerely acknowledges the Faculty Opportunity Award (FOA) that is administered by the Office of Sponsored Programs (OSP) at UNLV. P.K.B. sincerely acknowledges the MUREP Partnership Learning Annual Notification (MPLAN) Prize sponsored by NASA. P.K.B. also sincerely acknowledges the Knowledge Fund that is administered by the Nevada Governor’s Office of Economic Development (GOED) and the University of Nevada Las Vegas (UNLV). The authors also thank Chandigarh University, Gharuan, Punjab, India for providing all the basic facilities to carry out this research. All authors confirmed that no AI tools were used to prepare this manuscript.

Conflicts of Interest

The authors state that they do not have any conflicts of interest.

References

  1. Davarpanah, J.; Ghahremani, M.; Najafi, O. Synthesis of 1,4-Dihydropyridine and Polyhydroquinoline Derivatives via Hantzsch Reaction Using Nicotinic Acid as a Green and Reusable Catalyst. J. Mol. Struct. 2019, 1177, 525–535. [Google Scholar] [CrossRef]
  2. Bhaskaruni, S.V.H.S.; Maddila, S.; Van Zyl, W.E.; Jonnalagadda, S.B. Four-Component Fusion Protocol with NiO/ZrO2 as a Robust Recyclable Catalyst for Novel 1,4-Dihydropyridines. ACS Omega 2019, 4, 21187–21196. [Google Scholar] [CrossRef] [PubMed]
  3. Evdokimov, N.M.; Kireev, A.S.; Yakovenko, A.A.; Antipin, M.Y.; Magedov, I.V.; Kornienko, A. One-Step Synthesis of Heterocyclic Privileged Medicinal Scaffolds by a Multicomponent Reaction of Malononitrile with Aldehydes and Thiols. J. Org. Chem. 2007, 72, 3443–3453. [Google Scholar] [CrossRef] [PubMed]
  4. Evdokimov, N.M.; Magedov, I.V.; Kireev, A.S.; Kornienko, A. One-Step, Three-Component Synthesis of Pyridines and 1,4-Dihydropyridines with Manifold Medicinal Utility. Org. Lett. 2006, 8, 899–902. [Google Scholar] [CrossRef]
  5. Trivedi, A.; Dodiya, D.; Dholariya, B.; Kataria, V.; Bhuva, V.; Shah, V. Synthesis and Biological Evaluation of Some Novel 1,4-Dihydropyridines as Potential Antitubercular Agents. Chem. Biol. Drug Des. 2011, 78, 881–886. [Google Scholar] [CrossRef]
  6. Malhi, D.S.; Kaur, M.; Sohal, H.S. Effect of Substitutions on 1,4-Dihdropyridines to Achieve Potential Anti-Microbial Drugs: A Review. ChemistrySelect 2019, 4, 11321–11336. [Google Scholar] [CrossRef]
  7. Abdel-Mohsen, H.T.; Ragab, F.A.F.; Ramla, M.M.; El Diwani, H.I. Novel Benzimidazole–Pyrimidine Conjugates as Potent Antitumor Agents. Eur. J. Med. Chem. 2010, 45, 2336–2344. [Google Scholar] [CrossRef]
  8. Sirisha, K.; Achaiah, G.; Reddy, V.M. Facile Synthesis and Antibacterial, Antitubercular, and Anticancer Activities of Novel 1,4-Dihydropyridines. Arch. Pharm. 2010, 343, 342–352. [Google Scholar] [CrossRef]
  9. Zhou, B.; Xing, C. Diverse Molecular Targets for Chalcones with Varied Bioactivities. Med. Chem. 2015, 5, 388–404. [Google Scholar] [CrossRef]
  10. Martha, R.; Gutierrez, P.; Muñiz-ramirez, A.; Sauceda, J.V. Review: The Potential of Chalcones as a Source of Drugs. Afr. J. Pharm. Pharmacol. 2015, 9, 237–257. [Google Scholar] [CrossRef]
  11. Zhou, J.; Wan, F.; Xiao, B.; Li, X.; Peng, C.; Peng, F. Metochalcone Induces Senescence-Associated Secretory Phenotype via JAK2/STAT3 Pathway in Breast Cancer. Oncol. Res. 2024, 32, 943–953. [Google Scholar] [CrossRef]
  12. Lin, S.; Chen, Y.; Li, H.; Liu, J.; Liu, S. Design, Synthesis, and Evaluation of Amphiphilic Sofalcone Derivatives as Potent Gram-Positive Antibacterial Agents. Eur. J. Med. Chem. 2020, 202, 112596. [Google Scholar] [CrossRef]
  13. Yadav, V.R.; Prasad, S.; Sung, B.; Aggarwal, B.B. The Role of Chalcones in Suppression of NF-ΚB-Mediated Inflammation and Cancer. Int. Immunopharmacol. 2011, 11, 295–309. [Google Scholar] [CrossRef]
  14. Mohamed, M.F.; Darweesh, A.F.; Elwahy, A.H.M.; Abdelhamid, I.A. Synthesis, Characterization and Antitumor Activity of Novel Tetrapodal 1,4-Dihydropyridines: P53 Induction, Cell Cycle Arrest and Low Damage Effect on Normal Cells Induced by Genotoxic Factor H2O2. RSC Adv. 2016, 6, 40900–40910. [Google Scholar] [CrossRef]
  15. Huang, Y.; Liao, J.; Wang, W.; Liu, H.; Guo, H. Synthesis of Heterocyclic Compounds through Nucleophilic Phosphine Catalysis. Chem. Commun. 2020, 56, 15235–15281. [Google Scholar] [CrossRef] [PubMed]
  16. Rucins, M.; Plotniece, A.; Bernotiene, E.; Tsai, W.B.; Sobolev, A. Recent Approaches to Chiral 1,4-Dihydropyridines and Their Fused Analogues. Catalysts 2020, 10, 1019. [Google Scholar] [CrossRef]
  17. Kumar, A.; Maurya, R.A.; Sharma, S.; Kumar, M.; Bhatia, G. Synthesis and Biological Evaluation of N-Aryl-1,4-Dihydropyridines as Novel Antidyslipidemic and Antioxidant Agents. Eur. J. Med. Chem. 2010, 45, 501–509. [Google Scholar] [CrossRef]
  18. Sutarni, Y.D.; Purwono, B.; Kunarti, E.S.; Mardjan, M.I.D. Fe/ZSM-5-Catalyzed-Synthesis of 1,4-Dihydropyridines under Ultrasound Irradiation and Their Antioxidant Activities. Sains Malaysiana 2023, 52, 1189–1202. [Google Scholar] [CrossRef]
  19. De Luca, M.; Ioele, G.; Ragno, G. 1,4-Dihydropyridine Antihypertensive Drugs: Recent Advances in Photostabilization Strategies. Pharmaceutics 2019, 11, 85. [Google Scholar] [CrossRef]
  20. Maheswara, M.; Siddaiah, V.; Rao, Y.K.; Tzeng, Y.M.; Sridhar, C. A Simple and Efficient One-Pot Synthesis of 1,4-Dihydropyridines Using Heterogeneous Catalyst under Solvent-Free Conditions. J. Mol. Catal. A Chem. 2006, 260, 179–180. [Google Scholar] [CrossRef]
  21. Kalhor, S.; Yarie, M.; Rezaeivala, M.; Zolfigol, M.A. Novel Magnetic Nanoparticles with Morpholine Tags as Multirole Catalyst for Synthesis of Hexahydroquinolines and 2-Amino-4,6-Diphenylnicotinonitriles through Vinylogous Anomeric-Based Oxidation. Res. Chem. Intermed. 2019, 45, 3453–3480. [Google Scholar] [CrossRef]
  22. Parthiban, A.; Makam, P. 1,4-Dihydropyridine: Synthetic Advances, Medicinal and Insecticidal Properties. RSC Adv. 2022, 12, 29253–29290. [Google Scholar] [CrossRef]
  23. Wan, J.P.; Liu, Y. Recent Advances in New Multicomponent Synthesis of Structurally Diversified 1,4-Dihydropyridines. RSC Adv. 2012, 2, 9763–9777. [Google Scholar] [CrossRef]
  24. Sharma, V.K.; Singh, S.K. Synthesis, Utility and Medicinal Importance of 1,2- & 1,4-Dihydropyridines. RSC Adv. 2017, 7, 2682–2732. [Google Scholar] [CrossRef]
  25. Moradi, S.; Moradian, M.; Naeimi, H. Efficient One-Pot Synthesis of 1,4-Dihydropyridines Catalyzed by Magnetic MnFe2O4 Nanoparticles. Acta Chim. Slov. 2022, 69, 349–358. [Google Scholar] [CrossRef] [PubMed]
  26. Koukabi, N.; Kolvari, E.; Khazaei, A.; Zolfigol, M.A.; Shirmardi-Shaghasemi, B.; Khavasi, H.R. Hantzsch Reaction on Free Nano-Fe2O3 Catalyst: Excellent Reactivity Combined with Facile Catalyst Recovery and Recyclability. Chem. Commun. 2011, 47, 9230–9232. [Google Scholar] [CrossRef]
  27. Li, J.; He, P.; Yu, C. DPTA-Catalyzed One-Pot Regioselective Synthesis of Polysubstituted Pyridines and 1,4-Dihydropyridines. Tetrahedron 2012, 68, 4138–4144. [Google Scholar] [CrossRef]
  28. Olejníková, P.; Švorc, L.; Olšovská, D.; Panáková, A.; Vihonská, Z.; Kovaryová, K.; Marchalín, Š. Antimicrobial Activity of Novel C2-Substituted 1,4-Dihydropyridine Analogues. Sci. Pharm. 2014, 82, 221–232. [Google Scholar] [CrossRef]
  29. Sobhanardakani, S.; Jafari, A.; Zandipak, R.; Meidanchi, A. Removal of Heavy Metal (Hg(II) and Cr(VI)) Ions from Aqueous Solutions Using Fe2O3@SiO2 Thin Films as a Novel Adsorbent. Process Saf. Environ. Prot. 2018, 120, 348–357. [Google Scholar] [CrossRef]
  30. Shahabadi, N.; Zendehcheshm, S.; Jamshidi, D.; Khademi, F.; Soltani, L. Green Synthesis of γ-Fe2O3@SiO2 Magnetic Nanoparticles Functionalized with Penciclovir Drug: Antiproliferative Effect, and Nucleic Acids (DNA and RNA) Interaction. J. Taibah Univ. Sci. 2024, 18, 2357820. [Google Scholar] [CrossRef]
  31. Hjiri, M.; Zahmouli, N.; Khouzami, K.; Mir, L.E.; Aida, M.S.; Moulaee, K.; Lemine, O.M.; Leonardi, S.G.; Neri, G. A Comparison of NO2 Sensing Characteristics of α- and γ-Iron Oxide-Based Solid-State Gas Sensors. Appl. Phys. A Mater. Sci. Process. 2020, 126, 788. [Google Scholar] [CrossRef]
  32. Drbohlavova, J.; Hrdy, R.; Adam, V.; Kizek, R.; Schneeweiss, O.; Hubalek, J. Preparation and Properties of Various Magnetic Nanoparticles. Sensors 2009, 9, 2352–2362. [Google Scholar] [CrossRef] [PubMed]
  33. Mushtaq, A.; Zhao, R.; Luo, D.; Dempsey, E.; Wang, X.; Iqbal, M.Z.; Kong, X. Magnetic Hydroxyapatite Nanocomposites: The Advances from Synthesis to Biomedical Applications. Mater. Des. 2021, 197, 109269. [Google Scholar] [CrossRef]
  34. Ramutshatsha-Makhwedzha, D.; Ngila, J.C.; Ndungu, P.G.; Nomngongo, P.N. Ultrasound Assisted Adsorptive Removal of Cr, Cu, Al, Ba, Zn, Ni, Mn, Co, and Ti from Seawater Using Fe2O3-SiO2-PAN Nanocomposite: Equilibrium Kinetics. J. Mar. Sci. Eng. 2019, 7, 133. [Google Scholar] [CrossRef]
  35. El-Attar, H.G.; Salem, M.A.; Ibrahim, S.A.; Bakr, E.A. Highly Efficient and Recyclable Novel Spindles Fe2O3@SiO2/In2O3 Nanomagnetic Catalyst Designed for Green Synthesis of Azomethine Compounds. Res. Chem. Intermed. 2023, 49, 469–489. [Google Scholar] [CrossRef]
  36. Fu, Y.; Yang, Y.; Tuersun, T.; Yu, Y.; Zhi, J. Simple Preparation and Highly Selective Detection of Silver Ions Using an Electrochemical Sensor Based on Sulfur-Doped Graphene and a 3,3′,5,5′-Tetramethylbenzidine Composite Modified Electrode. Analyst 2018, 143, 2076–2082. [Google Scholar] [CrossRef]
  37. Cai, X.; Yang, C.; Chen, L.; Li, R.; Du, C. The Dissolution Mechanism, Molecular Dynamics Simulation and Thermodynamic Analysis of Nirmatrelvir (Treatment of COVID-19) in Aqueous Ethanol Mixtures. J. Mol. Liq. 2023, 391, 123256. [Google Scholar] [CrossRef]
  38. Zondervan, R.; Kulzer, F.; Berkhout, G.C.G.; Orrit, M. Local Viscosity of Supercooled Glycerol near Tg Probed by Rotational Diffusion of Ensembles and Single Dye Molecules. Proc. Natl. Acad. Sci. USA 2007, 104, 12628–12633. [Google Scholar] [CrossRef]
  39. Rusdan, N.A.; Timmiati, S.N.; Isahak, W.N.; Yaakob, Z.; Lim, K.L.; Khaidar, D. Recent Application of Core-Shell Nanostructured Catalysts for CO2 Thermocatalytic Conversion Processes. Nanomaterials 2022, 12, 3877. [Google Scholar] [CrossRef]
  40. Raup, D.E.A.; Cardinal-David, B.; Holte, D.; Scheidt, K.A. Cooperative Catalysis by Carbenes and Lewis Acids in a Highly Stereoselective Route to Gamma-Lactams. Nat. Chem. 2010, 2, 766–771. [Google Scholar] [CrossRef]
  41. Kumar, A.; Rout, L.; Achary, L.S.K.; Mohanty, S.K.; Nayak, P.S.; Barik, B. Solvent Free Synthesis of Chalcones over Graphene Oxide-Supported MnO2 Catalysts Synthesized via Combustion Route. Mater. Chem. Phys. 2021, 259, 124019. [Google Scholar] [CrossRef]
  42. Vaishali; Sharma, S.; Sharma, P.; Das, D.K.; Vashistha, V.K.; Dhiman, J.; Sharma, R.; Kumar, R.; vir Singh, M.; Kumar, Y. Magnetic Nanoparticle-Catalysed Synthesis of Quinoline Derivatives: A Green and Sustainable Method. Heliyon 2024, 10, e40451. [Google Scholar] [CrossRef] [PubMed]
  43. Curti, C.; Gellis, A.; Vanelle, P. Synthesis of α,β-Unsaturated Ketones as Chalcone Analogues via a SRN1 Mechanism. Molecules 2007, 12, 797–804. [Google Scholar] [CrossRef]
  44. Hennessy, M.C.; O’Sullivan, T.P. Recent Advances in the Transesterification of β-Keto Esters. RSC Adv. 2021, 11, 22859–22920. [Google Scholar] [CrossRef] [PubMed]
  45. Zhang, X.; Niu, Y.; Li, Y.; Li, Y.; Zhao, J. Preparation and Thermal Stability of the Spindle α-Fe2O3@SiO2 Core–Shell Nanoparticles. J. Solid State Chem. 2014, 211, 69–74. [Google Scholar] [CrossRef]
  46. Nanda, A.; Kaur, N.; Kaur, M.; Husain, F.M.; Han, H.; Bhowmik, P.K.; Sohal, H.S. Synthesis and Antimicrobial Activity of (E)-1-Aryl-2-(1H-Tetrazol-5-Yl)Acrylonitrile Derivatives via [3+2] Cycloaddition Reaction Using Reusable Heterogeneous Nanocatalyst under Microwave Irradiation. Molecules 2024, 29, 4339. [Google Scholar] [CrossRef]
  47. Elkanzi, N.A.A.; Hrichi, H.; Alolayan, R.A.; Derafa, W.; Zahou, F.M.; Bakr, R.B. Synthesis of Chalcones Derivatives and Their Biological Activities: A Review. ACS omega 2022, 7, 27769–27786. [Google Scholar] [CrossRef]
Figure 1. FT−IR spectra of Fe2O3 and Fe2O3@SiO2 nanoparticles.
Figure 1. FT−IR spectra of Fe2O3 and Fe2O3@SiO2 nanoparticles.
Catalysts 15 00281 g001
Figure 2. (a) DLS, and (b) Zeta-potential analysis of Fe2O3 and Fe2O3@SiO2 nanoparticles.
Figure 2. (a) DLS, and (b) Zeta-potential analysis of Fe2O3 and Fe2O3@SiO2 nanoparticles.
Catalysts 15 00281 g002
Figure 3. XRD patterns of Fe2O3 and Fe2O3@SiO2 nanoparticles.
Figure 3. XRD patterns of Fe2O3 and Fe2O3@SiO2 nanoparticles.
Catalysts 15 00281 g003
Figure 4. (ac) SEM images of Fe2O3 and, (df) SEM images of Fe2O3@SiO2 nanoparticles.
Figure 4. (ac) SEM images of Fe2O3 and, (df) SEM images of Fe2O3@SiO2 nanoparticles.
Catalysts 15 00281 g004
Figure 5. Magnetization of hysteresis loop for Fe2O3 and Fe2O3@SiO2 nanoparticles.
Figure 5. Magnetization of hysteresis loop for Fe2O3 and Fe2O3@SiO2 nanoparticles.
Catalysts 15 00281 g005
Figure 6. The chalcones and chalcone-derived 1,4-dihydropyridine derivative (6ae, 7ae, 8ae).
Figure 6. The chalcones and chalcone-derived 1,4-dihydropyridine derivative (6ae, 7ae, 8ae).
Catalysts 15 00281 g006
Scheme 1. Proposed mechanism for the synthesis of 1,4-dihydropyridine derivatives from chalcone catalyzed by Fe2O3@SiO2 nanocatalyst.
Scheme 1. Proposed mechanism for the synthesis of 1,4-dihydropyridine derivatives from chalcone catalyzed by Fe2O3@SiO2 nanocatalyst.
Catalysts 15 00281 sch001
Scheme 2. Synthesis of chalcone derivatives 3ac by Claisen–Schmidt condensation.
Scheme 2. Synthesis of chalcone derivatives 3ac by Claisen–Schmidt condensation.
Catalysts 15 00281 sch002
Scheme 3. Synthesis of 1,4-dihydropyridine derivatives catalyzed by Fe2O3@SiO2 nanocatalyst.
Scheme 3. Synthesis of 1,4-dihydropyridine derivatives catalyzed by Fe2O3@SiO2 nanocatalyst.
Catalysts 15 00281 sch003
Table 1. Optimizing the amount of Fe2O3@SiO2 nanocatalyst on model reaction.
Table 1. Optimizing the amount of Fe2O3@SiO2 nanocatalyst on model reaction.
Catalysts 15 00281 i001
EntryFe2O3@SiO2 (mmol%)Time (minutes)Yield of 6a a,* (%)Yield of 7a a,* (%)Yield of 8a a,* (%)
1010514954
218747270
327898587
436939294
538919091
6310908990
746929194
856929293
a Yield refer to extraction of all crops. * Reaction conditions: chalcone (1 mmol), methyl-3-oxobutnoate (1 mmol, 0.116 g), ammonium acetate (1 mmol, 0.077 g), and ethanol (5 mL) at 80 watts.
Table 2. Optimization of solvent for 1,4-DHPs derivatives synthesis, i.e., 6a, 7a, and 8a.
Table 2. Optimization of solvent for 1,4-DHPs derivatives synthesis, i.e., 6a, 7a, and 8a.
Catalysts 15 00281 i002
EntrySolventTime (Minutes)Yield of 6a a,* (%)Yield of 7a a,* (%)Yield of 8a a,* (%)
1Polyethylene glycol20706869
2Ethylene glycol20727473
3Water15353638
4Acetonitrile14707268
5Glycerol15909189
6Ethanol7949593
7Methanol11828084
8DMSO30303234
9DMF25555556
10No solvent30---
a Yield refers to extraction of all crops. * Reaction conditions: chalcone (1 mmol), methyl-3-oxobutanoate (1 mmol, 0.116 g), ammonium acetate (1 mmol, 0.077 g), and Fe2O3@SiO2 nanocatalyst (3 mmol%) at 80 watts.
Table 3. The impact of power levels of microwave reactor for the synthesis of 1,4-DHPs derivatives.
Table 3. The impact of power levels of microwave reactor for the synthesis of 1,4-DHPs derivatives.
Catalysts 15 00281 i003
EntryWatts Time (minutes)Yield of 6a a,* (%)Yield of 7a a,* (%)Yield of 8a a,* (%)
17515797780
28012818082
3857929190
4904989698
5954969795
61005939192
a Yield refer to extraction of all crops. * Reaction conditions: chalcone (1 mmol), methyl-3-oxobutanoate (1 mmol, 0.116 g), ammonium acetate (1 mmol, 0.077 g), Fe2O3@SiO2 nanocatalyst (3 mmol%), and ethanol (5 mL).
Table 4. Reusability of Fe2O3@SiO2 nanocatalyst for 1,4-DHPs derivatives synthesis.
Table 4. Reusability of Fe2O3@SiO2 nanocatalyst for 1,4-DHPs derivatives synthesis.
Catalysts 15 00281 i004
EntryRunYield for 6a a,* (%)Yield for 7a a,* (%)Yield for 8a a,* (%)
1Fresh989698
21979597
32979496
43969496
54959395
a Yield refers to extraction of all crops. * Reaction conditions: chalcone (1 mmol), methyl-3-oxobutanoate (1 mmol, 0.116 g), ammonium acetate (1 mmol, 0.077 g), Fe2O3@SiO2 nanocatalyst (3 mmol%), and ethanol (5 mL).
Table 5. Comparison of synthesis time, yield, and melting points of chalcone-derived 1,4-dihydropyridine derivatives.
Table 5. Comparison of synthesis time, yield, and melting points of chalcone-derived 1,4-dihydropyridine derivatives.
Catalysts 15 00281 i005
EntryChalcone-Derived 1,4-DHPs DerivativesRfYield (%)Melting Point (°C)Reference
LitExp
16a0.7894153–155156–157[13]
26b0.7992162–164164–166[20]
36c0.7596270–271271–272[13]
46d0.7393260–261263–265[28]
56e0.7195202–203204–205[28]
67a0.6694131–133133–134[13]
77b0.6797150–152151–153[20]
87c0.6492239–240239–241[28]
97d0.6391234–235236–238[20]
107e0.6294210–211202–204[28]
118a0.6790170–171172–173[20]
128b0.6893185–187187–188[13]
138c0.6295284–286286–288[28]
148d0.6196288–290289–291[20]
158e0.5993212–214215–216[20]
Table 6. The antimicrobial activity of chalcone-derived 1,4-dihydropyridine derivatives (6ae, 7ae, and 8ae).
Table 6. The antimicrobial activity of chalcone-derived 1,4-dihydropyridine derivatives (6ae, 7ae, and 8ae).
Chalcone-Derived 1,4-DPHs
Derivatives
Gram (+ve) BacteriaGram (-ve) BacteriaFungi
B.
Subtilis
S.
Pyogenes
E.
Coli
K.
Pneumonia
S.
Aureus
A.
Janus
A.
Niger
A.
Sclerotiorum
6a12846641283264128
6b12864643264128128128
6c323264646432128
6d12864641281286412864
6e128128128128128128
7a646412864323264128
7b643232326464332
7c816168816816
7d32888328328
7e16328321632816
8a321616163216816
8b321616163216816
8c44844482
8d816163216161616
8e323232161616328
Amoxicillin44444
Fluconazole222
“–” means no activities found against selected microbial strains.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Malhi, D.S.; Kaur, N.; Kaur, M.; Han, H.; Bhowmik, P.K.; Husain, F.M.; Sohal, H.S.; Verma, M. Synthesis and Antimicrobial Activity of Chalcone-Derived 1,4-Dihydropyridine Derivatives Using Magnetic Fe2O3@SiO2 as Highly Efficient Nanocatalyst. Catalysts 2025, 15, 281. https://doi.org/10.3390/catal15030281

AMA Style

Malhi DS, Kaur N, Kaur M, Han H, Bhowmik PK, Husain FM, Sohal HS, Verma M. Synthesis and Antimicrobial Activity of Chalcone-Derived 1,4-Dihydropyridine Derivatives Using Magnetic Fe2O3@SiO2 as Highly Efficient Nanocatalyst. Catalysts. 2025; 15(3):281. https://doi.org/10.3390/catal15030281

Chicago/Turabian Style

Malhi, Dharambeer Singh, Navneet Kaur, Manvinder Kaur, Haesook Han, Pradip K. Bhowmik, Fohad Mabood Husain, Harvinder Singh Sohal, and Meenakshi Verma. 2025. "Synthesis and Antimicrobial Activity of Chalcone-Derived 1,4-Dihydropyridine Derivatives Using Magnetic Fe2O3@SiO2 as Highly Efficient Nanocatalyst" Catalysts 15, no. 3: 281. https://doi.org/10.3390/catal15030281

APA Style

Malhi, D. S., Kaur, N., Kaur, M., Han, H., Bhowmik, P. K., Husain, F. M., Sohal, H. S., & Verma, M. (2025). Synthesis and Antimicrobial Activity of Chalcone-Derived 1,4-Dihydropyridine Derivatives Using Magnetic Fe2O3@SiO2 as Highly Efficient Nanocatalyst. Catalysts, 15(3), 281. https://doi.org/10.3390/catal15030281

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop